{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:20:29Z","timestamp":1784204429040,"version":"3.55.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T00:00:00Z","timestamp":1625702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001732","name":"Danmarks Grundforskningsfond","doi-asserted-by":"publisher","award":["DNRF126"],"award-info":[{"award-number":["DNRF126"]}],"id":[{"id":"10.13039\/501100001732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jtct.2021.07.001","type":"journal-article","created":{"date-parts":[[2021,7,10]],"date-time":"2021-07-10T01:23:38Z","timestamp":1625880218000},"page":"866.e1-866.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Platelet and Red Blood Cell Transfusions and Risk of Acute Graft-versus-Host Disease after Myeloablative Allogeneic Hematopoietic Cell Transplantation"],"prefix":"10.1016","volume":"27","author":[{"given":"Lars Klingen","family":"Gj\u00e6rde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4537-2505","authenticated-orcid":false,"given":"Anne Louise T\u00f8lb\u00f8ll","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob Hjorth","family":"von Stemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Fischer-Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten Bagge","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Sengel\u00f8v","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisse Rye","family":"Ostrowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2021.07.001_bib0001","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/bmt.2016.18","article-title":"Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey","volume":"51","author":"Niederwieser","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.07.001_bib0002","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMra1609337","article-title":"Acute graft-versus-host disease - biologic process, prevention, and therapy","volume":"377","author":"Zeiser","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2021.07.001_bib0003","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.bbmt.2012.04.005","article-title":"First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation","volume":"18","author":"Martin","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.07.001_bib0004","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/bmt.2016.298","article-title":"The EBMT-ELN working group recommendations on the prophylaxis and treatment of GvHD: a change-control analysis","volume":"52","author":"Ruutu","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.07.001_bib0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000441507","article-title":"ABO-Mismatched allogeneic hematopoietic stem cell transplantation","volume":"43","author":"Worel","year":"2016","journal-title":"Transfus Med Hemother"},{"key":"10.1016\/j.jtct.2021.07.001_bib0006","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1200\/JCO.19.01836","article-title":"Liberal versus restrictive red blood cell transfusion thresholds in hematopoietic cell transplantation: a randomized, open-label, phase III noninferiority trial","volume":"38","author":"Tay","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2021.07.001_bib0007","article-title":"Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support","volume":"1","author":"Estcourt","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jtct.2021.07.001_bib0008","article-title":"A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation","volume":"9","author":"Crighton","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jtct.2021.07.001_bib0009","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa1212772","article-title":"A no-prophylaxis platelet-transfusion strategy for hematologic cancers","volume":"368","author":"Stanworth","year":"2013","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"10.1016\/j.jtct.2021.07.001_bib0010","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/10245330512331390447","article-title":"Transfusion immunomodulation or TRIM: what does it mean clinically?","volume":"10","author":"Blajchman","year":"2005","journal-title":"Hematology"},{"key":"10.1016\/j.jtct.2021.07.001_bib0011","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.blre.2007.07.003","article-title":"Transfusion-related immunomodulation (TRIM): an update","volume":"21","author":"Vamvakas","year":"2007","journal-title":"Blood Rev"},{"key":"10.1016\/j.jtct.2021.07.001_bib0012","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s12026-009-8106-9","article-title":"The platelet as an immune cell-CD40 ligand and transfusion immunomodulation","volume":"45","author":"Blumberg","year":"2009","journal-title":"Immunol Res"},{"key":"10.1016\/j.jtct.2021.07.001_bib0013","first-page":"253","article-title":"Effect of blood transfusions on subsequent kidney transplants","volume":"5","author":"Opelz","year":"1973","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jtct.2021.07.001_bib0014","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1161\/CIRCULATIONAHA.107.698977","article-title":"Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery","volume":"116","author":"Murphy","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jtct.2021.07.001_bib0015","doi-asserted-by":"crossref","first-page":"6999","DOI":"10.4049\/jimmunol.1000929","article-title":"Platelets contribute to allograft rejection through glutamate receptor signaling","volume":"185","author":"Swaim","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.jtct.2021.07.001_bib0016","doi-asserted-by":"crossref","first-page":"133","DOI":"10.5045\/br.2013.48.2.133","article-title":"Prognostic effect of blood transfusion in children with acute lymphoblastic leukemia","volume":"48","author":"Alkayed","year":"2013","journal-title":"Blood Res"},{"key":"10.1016\/j.jtct.2021.07.001_bib0017","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s13577-019-00297-7","article-title":"Risk factors associated with the development of moderate to severe chronic graft-versus-host disease after non-myeloablative conditioning allogeneic stem cell transplantation in patients with AML or MDS","volume":"33","author":"Kok","year":"2020","journal-title":"Hum Cell"},{"key":"10.1016\/j.jtct.2021.07.001_bib0018","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/trf.12817","article-title":"Impact of platelet transfusion on toxicity and mortality after hematopoietic progenitor cell transplantation","volume":"55","author":"Christou","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.jtct.2021.07.001_bib0019","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/trf.12396","article-title":"The association between red blood cell and platelet transfusion and subsequently developing idiopathic pneumonia syndrome after hematopoietic stem cell transplantation","volume":"54","author":"Vande Vusse","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.jtct.2021.07.001_bib0020","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/pbc.22957","article-title":"Is the number of blood products transfused associated with lower survival in children with acute lymphoblastic leukemia?","volume":"57","author":"Jaime-P\u00e9rez","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jtct.2021.07.001_bib0021","first-page":"1220","article-title":"Transfusions and risk of failure in childhood acute lymphoblastic leukemia","volume":"8","author":"Freiberg","year":"1994","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2021.07.001_bib0022","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.bbmt.2018.01.003","article-title":"Peritransplantation red blood cell transfusion is associated with increased risk of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"24","author":"Hosoba","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"suppl 1","key":"10.1016\/j.jtct.2021.07.001_bib0023","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1053\/j.seminhematol.2016.04.002","article-title":"The nonhemostatic immune functions of platelets","volume":"53","author":"Kapur","year":"2016","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jtct.2021.07.001_bib0024","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nri2956","article-title":"Platelets and the immune continuum","volume":"11","author":"Semple","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jtct.2021.07.001_bib0025","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.07.001_bib0026","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jamainternmed.2016.3324","article-title":"Association of blood donor age and sex with recipient survival after red blood cell transfusion","volume":"176","author":"Chass\u00e9","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jtct.2021.07.001_bib0027","series-title":"Flexible Imputation of Missing Data","first-page":"77","article-title":"Predictive mean matching","author":"van Buuren","year":"2018"},{"key":"10.1016\/j.jtct.2021.07.001_bib0028","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/bmt.2016.140","article-title":"Impact of pretransplant red cell transfusion on outcome after allogeneic stem cell transplantation in adult patients with severe aplastic anemia","volume":"51","author":"Lee","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.07.001_bib0029","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1053\/tmrv.2002.35209","article-title":"Meta-analysis of randomized controlled trials investigating the risk of postoperative infection in association with white blood cell-containing allogeneic blood transfusion: the effects of the type of transfused red blood cell product and surgical setting","volume":"16","author":"Vamvakas","year":"2002","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.jtct.2021.07.001_bib0030","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/tme.12714","article-title":"Effect of leukoreduction on transfusion-related immunomodulation in patients undergoing cardiac surgery","volume":"30","author":"Khan","year":"2020","journal-title":"Transfus Med"},{"key":"10.1016\/j.jtct.2021.07.001_bib0031","article-title":"Leukoreduction for the prevention of adverse reactions from allogeneic blood transfusion","volume":"12","author":"Simancas-Racines","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jtct.2021.07.001_bib0032","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJM199712253372602","article-title":"The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto","volume":"337","author":"Rebulla","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2021.07.001_bib0033","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1056\/NEJMoa0904084","article-title":"Dose of prophylactic platelet transfusions and prevention of hemorrhage","volume":"362","author":"Slichter","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2021.07.001_bib0034","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0140-6736(12)60689-8","article-title":"Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study","volume":"380","author":"Wandt","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jtct.2021.07.001_bib0035","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1182\/asheducation-2008.1.198","article-title":"New strategies for the optimal use of platelet transfusions","author":"Blajchman","year":"2008","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jtct.2021.07.001_bib0036","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1111\/j.1537-2995.2008.01860.x","article-title":"Transfusion-associated immune modulation: a reason to TRIM platelet transfusions?","volume":"48","author":"Geiger","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.jtct.2021.07.001_bib0037","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.it.2004.07.003","article-title":"Platelets: signaling cells in the immune continuum","volume":"25","author":"Weyrich","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jtct.2021.07.001_bib0038","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.tmrv.2020.09.005","article-title":"The immune nature of platelets revisited","volume":"34","author":"Maouia","year":"2020","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.jtct.2021.07.001_bib0039","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1182\/bloodadvances.2018020834","article-title":"Megakaryocytes package contents into separate \u03b1-granules that are differentially distributed in platelets","volume":"3","author":"Battinelli","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2021.07.001_bib0040","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1182\/blood-2007-09-113837","article-title":"Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released","volume":"111","author":"Italiano","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.07.001_bib0041","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1111\/j.1537-2995.2008.01791.x","article-title":"Transfusion-related immunomodulation by platelets is dependent on their expression of MHC class I molecules and is independent of white cells","volume":"48","author":"Aslam","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.jtct.2021.07.001_bib0042","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1182\/blood-2013-08-523308","article-title":"Allogeneic platelet transfusions prevent murine T cell-mediated immune thrombocytopenia","volume":"123","author":"Guo","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.07.001_bib0043","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1213\/ane.0b013e3181948a59","article-title":"Platelet transfusion during liver transplantation is associated with increased postoperative mortality due to acute lung injury","volume":"108","author":"Pereboom","year":"2009","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jtct.2021.07.001_bib0044","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1053\/tm.1997.0110130","article-title":"The platelet storage lesion","volume":"11","author":"Seghatchian","year":"1997","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.jtct.2021.07.001_bib0045","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.tmrv.2018.04.001","article-title":"Platelet storage lesions: what more do we know now?","volume":"32","author":"Ng","year":"2018","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.jtct.2021.07.001_bib0046","first-page":"222","article-title":"Red blood cell storage time and transfusion: current practice, concerns and future perspectives","volume":"15","author":"Garc\u00eda-Roa","year":"2017","journal-title":"Blood Transfus"},{"key":"10.1016\/j.jtct.2021.07.001_bib0047","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/trf.12804","article-title":"An update on red blood cell storage lesions, as gleaned through biochemistry and omics technologies","volume":"55","author":"D'Alessandro","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.jtct.2021.07.001_bib0048","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/ALN.0b013e31818ddb72","article-title":"Blood transfusion promotes cancer progression: a critical role for aged erythrocytes","volume":"109","author":"Atzil","year":"2008","journal-title":"Anesthesiology"},{"issue":"suppl 1","key":"10.1016\/j.jtct.2021.07.001_bib0049","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/SHK.0000000000000089","article-title":"Role of transfused red blood cells for shock and coagulopathy within remote damage control resuscitation","volume":"41","author":"Spinella","year":"2014","journal-title":"Shock"},{"key":"10.1016\/j.jtct.2021.07.001_bib0050","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1111\/j.1537-2995.2011.03166.x","article-title":"Storage time of transfused red blood cells and impact on clinical outcomes in hematopoietic stem cell transplantation","volume":"51","author":"Kekre","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.jtct.2021.07.001_bib0051","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1001\/jama.2019.17478","article-title":"Effect of fresh vs standard-issue red blood cell transfusions on multiple organ dysfunction syndrome in critically ill pediatric patients: a randomized clinical trial","volume":"322","author":"Spinella","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.jtct.2021.07.001_bib0052","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/2012.jama.11953","article-title":"Effect of fresh red blood cell transfusions on clinical outcomes in premature, very low-birth-weight infants: the ARIPI randomized trial","volume":"308","author":"Fergusson","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jtct.2021.07.001_bib0053","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa1414219","article-title":"Effects of red-cell storage duration on patients undergoing cardiac surgery","volume":"372","author":"Steiner","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2021.07.001_bib0054","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1056\/NEJMoa1500704","article-title":"Age of transfused blood in critically ill adults","volume":"372","author":"Lacroix","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2021.07.001_bib0055","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa1609014","article-title":"Effect of short-term vs long-term blood storage on mortality after transfusion","volume":"375","author":"Heddle","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2021.07.001_bib0056","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1056\/NEJMoa1707572","article-title":"Age of red cells for transfusion and outcomes in critically ill adults","volume":"377","author":"Cooper","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2021.07.001_bib0057","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.annemergmed.2018.09.033","article-title":"Older blood is associated with increased mortality and adverse events in massively transfused trauma patients: secondary analysis of the PROPPR trial","volume":"73","author":"Jones","year":"2019","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jtct.2021.07.001_bib0058","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s13054-018-2114-x","article-title":"Platelet storage duration and its clinical and transfusion outcomes: a systematic review","volume":"22","author":"Aubron","year":"2018","journal-title":"Crit Care"},{"key":"10.1016\/j.jtct.2021.07.001_bib0059","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/vox.12443","article-title":"Effect of platelet storage time on platelet measurements: a systematic review and meta-analyses","volume":"111","author":"Caram-Deelder","year":"2016","journal-title":"Vox Sang"},{"key":"10.1016\/j.jtct.2021.07.001_bib0060","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/vox.12494","article-title":"Effect of storage time of platelet products on clinical outcomes after transfusion: a systematic review and meta-analyses","volume":"112","author":"Kreuger","year":"2017","journal-title":"Vox Sang"},{"key":"10.1016\/j.jtct.2021.07.001_bib0061","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1423-0410.2009.01197.x","article-title":"A randomized study of buffy coat platelets in platelet additive solution stored 1-5 versus 6-7 days prior to prophylactic transfusion of allogeneic haematopoietic progenitor cell transplant recipients","volume":"97","author":"Diedrich","year":"2009","journal-title":"Vox Sang"},{"key":"10.1016\/j.jtct.2021.07.001_bib0062","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1182\/blood-2010-12-322891","article-title":"IFN-\u03b3 and indoleamine 2,3-dioxygenase signaling between donor dendritic cells and T cells regulates graft-versus-host and graft-versus-leukemia activity","volume":"119","author":"Lu","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.07.001_bib0063","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1182\/blood-2007-03-083105","article-title":"Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells","volume":"110","author":"Hendrickson","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.07.001_bib0064","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1055\/s-0038-1648199","article-title":"Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells","volume":"65","author":"Ishii","year":"1991","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtct.2021.07.001_bib0065","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/BF00311430","article-title":"Increased plasma levels of soluble thrombomodulin in patients with sepsis and organ failure","volume":"25","author":"Iba","year":"1995","journal-title":"Surg Today"},{"key":"10.1016\/j.jtct.2021.07.001_bib0066","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1055\/s-0034-1398377","article-title":"Profound endothelial damage predicts impending organ failure and death in sepsis","volume":"41","author":"Johansen","year":"2015","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtct.2021.07.001_bib0067","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0268-960X(95)90028-4","article-title":"The role of cytokines in blood transfusion reactions","volume":"9","author":"Muylle","year":"1995","journal-title":"Blood Rev"},{"key":"10.1016\/j.jtct.2021.07.001_bib0068","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJM199409083311001","article-title":"The role of the plasma from platelet concentrates in transfusion reactions","volume":"331","author":"Heddle","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2021.07.001_bib0069","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1537-2995.1993.33393174443.x","article-title":"Increased tumor necrosis factor alpha (TNF alpha), interleukin 1, and interleukin 6 (IL-6) levels in the plasma of stored platelet concentrates: relationship between TNF alpha and IL-6 levels and febrile transfusion reactions","volume":"33","author":"Muylle","year":"1993","journal-title":"Transfusion"},{"key":"10.1016\/j.jtct.2021.07.001_bib0070","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/35393","article-title":"CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells","volume":"391","author":"Henn","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.jtct.2021.07.001_bib0071","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fmed.2018.00042","article-title":"The non-hemostatic aspects of transfused platelets","volume":"5","author":"Sut","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jtct.2021.07.001_bib0072","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.tracli.2012.02.003","article-title":"CD40 ligand (CD154) involvement in platelet transfusion reactions","volume":"19","author":"Sahler","year":"2012","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.jtct.2021.07.001_bib0073","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.1182\/blood-2008-05-157578","article-title":"Platelet components associated with acute transfusion reactions: the role of platelet-derived soluble CD40 ligand","volume":"112","author":"Cognasse","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.07.001_bib0074","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1182\/blood-2006-04-017251","article-title":"Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury","volume":"108","author":"Khan","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.07.001_bib0075","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1111\/j.1537-2995.2006.00979.x","article-title":"An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions","volume":"46","author":"Blumberg","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.jtct.2021.07.001_bib0076","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1182\/blood.2019000952","article-title":"Cytokines and costimulation in acute graft-versus-host disease","volume":"136","author":"Hill","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.07.001_bib0077","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3389\/fimmu.2016.00539","article-title":"Danger signals and graft-versus-host disease: current understanding and future perspectives","volume":"7","author":"Toubai","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2021.07.001_bib0078","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.1182\/bloodadvances.2020002677","article-title":"Associations of the gut microbiome and clinical factors with acute GVHD in allogeneic HSCT recipients","volume":"4","author":"Ilett","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2021.07.001_bib0079","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/bmt.2014.293","article-title":"Impact of conditioning intensity and TBI on acute GVHD after hematopoietic cell transplantation","volume":"50","author":"Nakasone","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.07.001_bib0080","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1182\/blood.V80.7.1838.1838","article-title":"Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate","volume":"80","author":"Nash","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.07.001_bib0081","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1182\/blood-2011-06-364265","article-title":"Risk factors for acute GVHD and survival after hematopoietic cell transplantation","volume":"119","author":"Jagasia","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.07.001_bib0082","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1182\/blood.V90.8.3204","article-title":"Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines","volume":"90","author":"Hill","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2021.07.001_bib0083","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.bbmt.2018.03.014","article-title":"Bad blood or sick patient?","volume":"24","author":"Sedhom","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.07.001_bib0084","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/bmt.2011.110","article-title":"The EBMT risk score","volume":"47","author":"Gratwohl","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2021.07.001_bib0085","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1182\/blood-2012-03-418202","article-title":"A disease risk index for patients undergoing allogeneic stem cell transplantation","volume":"120","author":"Armand","year":"2012","journal-title":"Blood"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636721010368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636721010368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:05:39Z","timestamp":1763003139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636721010368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":85,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S2666636721010368"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2021.07.001","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platelet and Red Blood Cell Transfusions and Risk of Acute Graft-versus-Host Disease after Myeloablative Allogeneic Hematopoietic Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2021.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}